Elanco
Animal Health Incorporated today announced it had entered into an agreement
with Bayer AG to acquire its animal health business in a transaction valued at
$7.6 billion. The transaction will be financed by a 70% cash/30% equity
combination.
Hengeler Mueller
advises Elanco on the acquisition together with Paul, Weiss, Rifkind, Wharton
& Garrison LLP (team is led by Tarun Stewart, New York). The Hengeler
Mueller team is led by partners Christian Möller and Maximilian Schiessl (both
M&A, Düsseldorf) and includes partners Hendrik Bockenheimer (Employment,
Frankfurt), Wolfgang Kellenter (IP, Düsseldorf), Matthias Scheifele (Tax,
München) and Dirk Uwer (Life Sciences / Public Law, Düsseldorf), counsel Markus
Ernst (Tax, München), Benedikt Migdal (IP, Düsseldorf), Eckbert Müller
(Employment, Frankfurt) and Ralf Willer (M&A, Berlin) as well as associates
Oda Goetzke, Marc Seeger, Tianyuan Zhuang, Johannes Fütterer, Benedikt Statz,
Alexander von Bernstorff (all Düsseldorf), Yenilee Ičagić (Berlin) (all
M&A), Susanne Koch (Life Sciences / Public Law), Julia Fischer, Norman
Koschmieder (both Public Law) (all Düsseldorf), Marius Mayer (Employment) and
Sebastian Heinrichs (Tax) (both Frankfurt).